Safety and target engagement of an oral small-molecule sequestrant in adolescents with autism spectrum disorder: an open-label phase 1b/2a trial

[1]  P. M. Thompson,et al.  Autism-related dietary preferences mediate autism-gut microbiome associations , 2021, Cell.

[2]  N. Glaichenhaus,et al.  The microbial metabolite p-Cresol induces autistic-like behaviors in mice by remodeling the gut microbiota , 2021, Microbiome.

[3]  C. Barbas,et al.  Metabolomics analysis of microbiota-gut-brain axis in neurodegenerative and psychiatric diseases. , 2020, Journal of pharmaceutical and biomedical analysis.

[4]  Brittany D. Needham,et al.  Gut microbial molecules in behavioural and neurodegenerative conditions , 2020, Nature Reviews Neuroscience.

[5]  J. M. Rodríguez,et al.  Autism Spectrum Disorder Associated With Gut Microbiota at Immune, Metabolomic, and Neuroactive Level , 2020, Frontiers in Neuroscience.

[6]  Brian K. Lee,et al.  Maternal Dietary Factors and the Risk of Autism Spectrum Disorders: A Systematic Review of Existing Evidence , 2020, Autism research : official journal of the International Society for Autism Research.

[7]  Y. Li,et al.  Untargeted Metabolomic Profiling Using UHPLC-QTOF/MS Reveals Metabolic Alterations Associated with Autism , 2020, BioMed research international.

[8]  O. Pedersen,et al.  Gut microbiota in human metabolic health and disease , 2020, Nature Reviews Microbiology.

[9]  Shih-Yi Lin,et al.  p-Cresol Sulfate Caused Behavior Disorders and Neurodegeneration in Mice with Unilateral Nephrectomy Involving Oxidative Stress and Neuroinflammation , 2020, International journal of molecular sciences.

[10]  M. A. Shchedrina,et al.  Amygdala: Neuroanatomical and Morphophysiological Features in Terms of Neurological and Neurodegenerative Diseases , 2020, Brain sciences.

[11]  C. Pieh,et al.  Metabolomic Biomarkers in Anxiety Disorders , 2020, International journal of molecular sciences.

[12]  Krzysztof Nosek,et al.  Neurobehavioral effects of uremic toxin–indoxyl sulfate in the rat model , 2020, Scientific Reports.

[13]  Mary C. Conrad,et al.  Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder , 2020, Biological Psychiatry.

[14]  J. Constantino,et al.  Early Identification of Autism Spectrum Disorder Among Children Aged 4 Years — Early Autism and Developmental Disabilities Monitoring Network, Six Sites, United States, 2016 , 2020, Morbidity and mortality weekly report. Surveillance summaries.

[15]  J. Michaelson,et al.  Forecasting risk gene discovery in autism with machine learning and genome-scale data , 2020, Scientific Reports.

[16]  N. Nagarajan,et al.  Gut microbiota changes in children with autism spectrum disorder: a systematic review , 2020, Gut Pathogens.

[17]  C. Lord,et al.  Autism spectrum disorder , 2020, Nature Reviews Disease Primers.

[18]  W. Garrett.  Immune recognition of microbial metabolites , 2019, Nature Reviews Immunology.

[19]  S. Rivera,et al.  A Randomized Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder , 2019, Front. Psychiatry.

[20]  James B. Adams,et al.  Multivariate Analysis of Plasma Metabolites in Children with Autism Spectrum Disorder and Gastrointestinal Symptoms Before and After Microbiota Transfer Therapy , 2019, Processes.

[21]  A. Thurm,et al.  Concordance of the Vineland Adaptive Behavior Scales, second and third editions. , 2019, Journal of intellectual disability research : JIDR.

[22]  Edmund T. Rolls,et al.  The cingulate cortex and limbic systems for emotion, action, and memory , 2019, Brain Structure and Function.

[23]  Alicia Guemez-Gamboa,et al.  Genetic Causes and Modifiers of Autism Spectrum Disorder , 2019, Front. Cell. Neurosci..

[24]  G. Feng,et al.  Anterior cingulate cortex dysfunction underlies social deficits in Shank3 mutant mice , 2019, Nature Neuroscience.

[25]  Young-Mo Kim,et al.  Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice , 2019, Cell.

[26]  R. Palmer,et al.  Efficacy and safety of memantine in children with autism spectrum disorder: Results from three phase 2 multicenter studies , 2019, Autism : the international journal of research and practice.

[27]  J. Caporaso,et al.  Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota , 2019, Scientific Reports.

[28]  Dina R. Dajani,et al.  Atypical frontoamygdala functional connectivity in youth with autism , 2018, Developmental Cognitive Neuroscience.

[29]  S. Likhitsathian,et al.  Aripiprazole in acute treatment of children and adolescents with autism spectrum disorder: a systematic review and meta-analysis , 2018, European Neuropsychopharmacology.

[30]  Ruth A. Carper,et al.  Atypical Functional Connectivity of Amygdala Related to Reduced Symptom Severity in Children With Autism. , 2018, Journal of the American Academy of Child and Adolescent Psychiatry.

[31]  Y. Trakadis,et al.  Metabolomics in patients with psychosis: A systematic review , 2018, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[32]  Satrajit S. Ghosh,et al.  FMRIPrep: a robust preprocessing pipeline for functional MRI , 2018, Nature Methods.

[33]  D. Pizzagalli,et al.  Nicotine normalizes cortico-striatal connectivity in non-smoking individuals with major depressive disorder , 2018, Neuropsychopharmacology.

[34]  P. Vourc'h,et al.  Identification of metabolic pathway disturbances using multimodal metabolomics in autistic disorders in a Middle Eastern population , 2018, Journal of pharmaceutical and biomedical analysis.

[35]  N. Pons,et al.  Indole, a Signaling Molecule Produced by the Gut Microbiota, Negatively Impacts Emotional Behaviors in Rats , 2018, Front. Neurosci..

[36]  Christopher H. Chatham,et al.  Adaptive behavior in autism: Minimal clinically important differences on the Vineland‐II , 2018, Autism research : official journal of the International Society for Autism Research.

[37]  Dae-Wook Kang,et al.  Differences in fecal microbial metabolites and microbiota of children with autism spectrum disorders. , 2018, Anaerobe.

[38]  R. Findling,et al.  An update on pharmacotherapy of autism spectrum disorder in children and adolescents , 2018, International review of psychiatry.

[39]  Justin M. Shepherd,et al.  Reduced interhemispheric executive control network coupling in men during early cocaine abstinence: A pilot study. , 2017, Drug and alcohol dependence.

[40]  Willa Xiong.  Pediatric Pharmacologic Management of Autism-Associated Behavioral Dysregulation , 2017 .

[41]  L. Atzori,et al.  The urinary 1H‐NMR metabolomics profile of an italian autistic children population and their unaffected siblings , 2017, Autism research : official journal of the International Society for Autism Research.

[42]  E. Cook,et al.  Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial , 2017, Neuropsychopharmacology.

[43]  C. Lord,et al.  Placebo‐like response in absence of treatment in children with Autism , 2017, Autism research : official journal of the International Society for Autism Research.

[44]  Satrajit S. Ghosh,et al.  Mindboggling morphometry of human brains , 2016, bioRxiv.

[45]  L. Zolla,et al.  Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism , 2016, Molecular Autism.

[46]  Zong-xin Ling,et al.  Maternal infection during pregnancy and risk of autism spectrum disorders: A systematic review and meta-analysis , 2016, Brain, Behavior, and Immunity.

[47]  G. A. Miller,et al.  Differential functional connectivity of rostral anterior cingulate cortex during emotional interference , 2016, Social cognitive and affective neuroscience.

[48]  A. Dale,et al.  Characterization and Correction of Geometric Distortions in 814 Diffusion Weighted Images , 2016, PloS one.

[49]  Li-juan Shi,et al.  Functional Connectivity of the Caudal Anterior Cingulate Cortex Is Decreased in Autism , 2016, PloS one.

[50]  M. Kerr,et al.  Untargeted plasma and tissue metabolomics in rats with chronic kidney disease given AST-120 , 2016, Scientific Reports.

[51]  A. Hardan,et al.  Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis , 2016, Pediatrics.

[52]  C. Andres,et al.  Metabolomics Study of Urine in Autism Spectrum Disorders Using a Multiplatform Analytical Methodology. , 2015, Journal of proteome research.

[53]  R. Findling,et al.  Lurasidone for the Treatment of Irritability Associated with Autistic Disorder , 2015, Journal of autism and developmental disorders.

[54]  E. Storch,et al.  Defining Treatment Response and Symptom Remission for Anxiety Disorders in Pediatric Autism Spectrum Disorders Using the Pediatric Anxiety Rating Scale , 2015, Journal of autism and developmental disorders.

[55]  Alberto Llera,et al.  ICA-AROMA: A robust ICA-based strategy for removing motion artifacts from fMRI data , 2015, NeuroImage.

[56]  A. Zimmerman,et al.  Sulforaphane treatment of autism spectrum disorder (ASD) , 2014, Proceedings of the National Academy of Sciences.

[57]  D. Rossignol,et al.  Environmental toxicants and autism spectrum disorders: a systematic review , 2014, Translational Psychiatry.

[58]  Timothy O. Laumann,et al.  Methods to detect, characterize, and remove motion artifact in resting state fMRI , 2014, NeuroImage.

[59]  J. Petrosino,et al.  Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders , 2013, Cell.

[60]  Marco Gobbetti,et al.  Fecal Microbiota and Metabolome of Children with Autism and Pervasive Developmental Disorder Not Otherwise Specified , 2013, PloS one.

[61]  Raphael T. Gerraty,et al.  An improved framework for confound regression and filtering for control of motion artifact in the preprocessing of resting-state functional connectivity data , 2013, NeuroImage.

[62]  Lining Guo,et al.  Metabolic perturbance in autism spectrum disorders: a metabolomics study. , 2012, Journal of proteome research.

[63]  D. Louis Collins,et al.  Brain templates and atlases , 2012, NeuroImage.

[64]  D. Elbe,et al.  Review of the pharmacotherapy of irritability of autism. , 2012, Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent.

[65]  M. Angley,et al.  Elevated Fecal Short Chain Fatty Acid and Ammonia Concentrations in Children with Autism Spectrum Disorder , 2012, Digestive Diseases and Sciences.

[66]  J. Kałużna-Czaplińska.  Noninvasive urinary organic acids test to assess biochemical and nutritional individuality in autistic children. , 2011, Clinical biochemistry.

[67]  J. Veenstra-VanderWeele,et al.  A Systematic Review of Secretin for Children With Autism Spectrum Disorders , 2011, Pediatrics.

[68]  Zachary Warren,et al.  A Systematic Review of Early Intensive Intervention for Autism Spectrum Disorders , 2011, Pediatrics.

[69]  Bruce Fischl,et al.  Highly accurate inverse consistent registration: A robust approach , 2010, NeuroImage.

[70]  Brian B. Avants,et al.  N4ITK: Improved N3 Bias Correction , 2010, IEEE Transactions on Medical Imaging.

[71]  C. Drew.  Vineland Adaptive Behavior Scales , 2010 .

[72]  R. Mcquade,et al.  A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. , 2009, Journal of the American Academy of Child and Adolescent Psychiatry.

[73]  Bruce Fischl,et al.  Accurate and robust brain image alignment using boundary-based registration , 2009, NeuroImage.

[74]  T. Kemper,et al.  The anterior cingulate cortex in autism: heterogeneity of qualitative and quantitative cytoarchitectonic features suggests possible subgroups , 2009, Acta Neuropathologica.

[75]  C. Almli,et al.  Unbiased nonlinear average age-appropriate brain templates from birth to adulthood , 2009, NeuroImage.

[76]  J. Bregman,et al.  Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. , 2009, Archives of general psychiatry.

[77]  T. Miyakawa,et al.  Elevated Plus Maze for Mice , 2008, Journal of visualized experiments : JoVE.

[78]  Katharine N. Thakkar,et al.  Response monitoring, repetitive behaviour and anterior cingulate abnormalities in autism spectrum disorders (ASD) , 2008, Brain : a journal of neurology.

[79]  Brian B. Avants,et al.  Symmetric diffeomorphic image registration with cross-correlation: Evaluating automated labeling of elderly and neurodegenerative brain , 2008, Medical Image Anal..

[80]  Thomas T. Liu,et al.  A component based noise correction method (CompCor) for BOLD and perfusion based fMRI , 2007, NeuroImage.

[81]  M. Aman,et al.  The Repetitive Behavior Scale-Revised: Independent Validation in Individuals with Autism Spectrum Disorders , 2007, Journal of autism and developmental disorders.

[82]  P. Malhi,et al.  Risperidone in Children With Autism: Randomized, Placebo-Controlled, Double-Blind Study , 2006, Journal of child neurology.

[83]  Jennifer L. Martin,et al.  Human sulfotransferases and their role in chemical metabolism. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[84]  J. Buitelaar,et al.  Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study. , 2005, Journal of the American Academy of Child and Adolescent Psychiatry.

[85]  Michael Brady,et al.  Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.

[86]  L. Ritz,et al.  The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties. , 2002, Journal of the American Academy of Child and Adolescent Psychiatry.

[87]  Anders M. Dale,et al.  Cortical Surface-Based Analysis I. Segmentation and Surface Reconstruction , 1999, NeuroImage.

[88]  R W Cox,et al.  Software tools for analysis and visualization of fMRI data , 1997, NMR in biomedicine.

[89]  I. Wiklund,et al.  Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. , 1995, Scandinavian journal of gastroenterology.

[90]  J. Virjee,et al.  Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate. , 1990, BMJ.

[91]  Yeonsoo Kim,et al.  Sulforaphane treatment for autism spectrum disorder: A systematic review. , 2020, EXCLI journal.

[92]  T. Grace,et al.  Role of the Gut Microbiome in Autism Spectrum Disorders. , 2019, Advances in experimental medicine and biology.

[93]  Tony Charman,et al.  Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology , 2018, Journal of psychopharmacology.

[94]  M. Aman,et al.  Validity of the Aberrant Behavior Checklist in Children with Autism Spectrum Disorder , 2014, Journal of autism and developmental disorders.

[95]  Stephen M. Smith,et al.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm , 2001, IEEE Transactions on Medical Imaging.

[96]  K. Maeda,et al.  Oral sorbent suppresses accumulation of albumin-bound indoxyl sulphate in serum of haemodialysis patients. , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[97]  C. Lanczos.  Evaluation of Noisy Data , 1964 .